Abstract The clinical course of a Paroxysmal Nocturnal Hemoglobinuria (PNH) patient receiving treatment with terminal complement by ravulizumab and SARS-CoV2…
![](https://analesranm.es/wp-content/uploads/2018/08/user_mujer.jpg)
Yang Dai
Alexion Pharmaceuticals, Inc., Boston, MA
Abstract The clinical course of a Paroxysmal Nocturnal Hemoglobinuria (PNH) patient receiving treatment with terminal complement by ravulizumab and SARS-CoV2…